Synthex Inc
SyntheX Inc, based in San Francisco, is at the forefront of drug discovery, utilizing its innovative ToRFLEx platform to engineer cells for target-centric, cell-based functional selection. The company aims to expand access to the vast majority of human proteins that have historically been considered inaccessible as drug targets, focusing on novel mechanisms of action to modulate protein levels and their interactions.
By leveraging synthetic biology, SyntheX is not only enhancing the efficiency and cost-effectiveness of drug discovery but also unlocking new pharmacological avenues and complex mechanisms of action. Their approach seeks to identify rare and selective drugs that can address challenging protein targets, ultimately contributing to the advancement of precision medicine.
Generated from the website
Also at this address
You might also like
Partial Data by Infogroup (c) 2025. All rights reserved.